ESMO @ ECC 2015: Regional Hyperthermia Added to Neoadjuvant Chemotherapy Doubles Length of Overall Survival in Patients With Localised High-Risk Soft Tissue Sarcoma
Long-term follow-up of EORTC study strongly supports adding regional hyperthermia to neoadjuvant chemotherapy